---
title: "Prism Medico & Pharmacy Ltd (512217) — Share Price, Financials & Analysis"
symbol: "512217"
company: "Prism Medico & Pharmacy Ltd"
canonical: "https://tapetide.com/stocks/512217"
isin: "INE730E01016"
nse_symbol: "PRISMMEDICOPHARMACYLTD"
bse_code: "512217"
sector: "Financial Services"
industry: "NBFC"
market_cap_cr: 40.63
generated_at: "2026-09-13T18:59:00.773Z"
---

# Prism Medico & Pharmacy Ltd (512217)

Canonical page: https://tapetide.com/stocks/512217

## Company

- **NSE Symbol:** PRISMMEDICOPHARMACYLTD
- **BSE Code:** 512217
- **ISIN:** INE730E01016
- **Sector:** Financial Services
- **Industry:** NBFC
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** prismmedicos.com

## About

Incorporated in 1985, Prism Medico & Pharmacy Ltd manufactures, trades, and distributes chemicals, medicines, pharmaceuticals, cosmetics, and related products[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:44:59.297537Z.

- **Market Cap:** ₹40.63 Cr
- **Classification:** Microcap
- **P/E (reported):** -102.6
- **EPS (TTM):** ₹-0.59
- **EPS (reported):** ₹0
- **Book Value:** ₹16.89
- **Price to Book:** 1.76
- **Dividend Yield:** 0%
- **ROE:** 0.31%
- **ROCE:** 0.08%
- **Debt to Equity:** 0.17
- **Revenue (yearly):** ₹54.7 Cr
- **Net Income:** ₹0 Cr
- **EBITDA:** ₹0.4 Cr
- **52-Week High:** ₹34.49
- **52-Week Low:** ₹15.51
- **RSI (14):** 55.96

## Tapetide Score

- **Score:** 45 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 28.3 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 75%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 17.81 | 9% |
| growth | 15.95 | 9% |
| momentum | 89.17 | 12% |
| ownership | 48.04 | 24% |
| quality | 50 | 22% |
| valuation | 42.04 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 1.17 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- Promoter holding is low: 30.0%
- Company has a low return on equity of 0.55% over last 3 years.
- Company has high debtors of 595 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -112.39% | -0.44% | -100.53% |
| ebitda margin growth | -100% | -79.55% | -70.73% | — |
| net income growth | -100% | -156% | 82% | 35% |
| revenue growth | 48.48% | 139.91% | 24% | -32% |
| roce | -80% | -97.09% | -117.02% | — |
| roe | -144.44% | — | -0.47% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Revenue | 0.03 | 2.75 | 0.15 | 0.06 | 0.29 | 0.21 | 0.07 | 1.59 | 0.5 | 0.07 | 0.28 | 0 |
| Expenses | 0.09 | 2.56 | 0.32 | 0.15 | 0.28 | 0.22 | 0.06 | 0.94 | 0.6 | 0.09 | 0.4 | 0.15 |
| Financing Profit | -0.06 | 0.19 | -0.17 | -0.09 | 0.01 | -0.01 | 0.01 | 0.65 | -0.1 | -0.02 | -0.12 | -0.15 |
| Financing Margin % | -200 | 6.91 | -113.33 | -150 | 3.45 | -4.76 | 14.29 | 40.88 | -20 | -28.57 | -42.86 | — |
| Other Income | 0.01 | 0 | 0.1 | 0 | 0 | 0 | 0.01 | 0 | 0.02 | 0.01 | 0 | 0.09 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.05 | 0.19 | -0.07 | -0.09 | 0.01 | -0.01 | 0.02 | 0.65 | -0.08 | -0.01 | -0.12 | -0.06 |
| Tax % | 0 | 0 | -14.29 | 0 | 0 | 0 | -100 | -1.54 | 0 | 0 | 100 | 0 |
| Net Profit | -0.05 | 0.19 | -0.07 | -0.09 | 0.01 | -0.01 | 0.04 | 0.66 | -0.08 | -0.01 | -0.24 | -0.06 |
| EPS in Rs | -0.08 | 0.31 | -0.12 | -0.15 | 0.02 | -0.02 | 0.07 | 1.09 | -0.13 | -0.02 | -0.4 | -0.04 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Revenue | 20.96 | 36.31 | 26.89 | 16.76 | 8.44 | 1.27 | 2.93 | 0.63 | 2.41 | 0.85 |
| Expenses | 20.86 | 35.98 | 26.94 | 16.92 | 8.93 | 1.37 | 3.06 | 0.71 | 2.01 | 1.24 |
| Financing Profit | 0.1 | 0.33 | -0.05 | -0.16 | -0.49 | -0.1 | -0.14 | -0.08 | 0.4 | -0.39 |
| Financing Margin % | 0.48 | 0.91 | -0.19 | -0.95 | -5.81 | -7.87 | -4.78 | -12.7 | 16.6 | -45.88 |
| Other Income | -0.01 | -0.01 | 0 | 0 | 0 | 0 | 0.12 | 0.02 | 0.03 | 0.12 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| Depreciation | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
| Profit before tax | 0.05 | 0.29 | -0.07 | -0.17 | -0.5 | -0.11 | -0.03 | -0.06 | 0.43 | -0.27 |
| Tax % | 140 | -24.14 | -28.57 | -29.41 | -26 | -27.27 | -33.33 | -33.33 | 25.58 | — |
| Net Profit | -0.02 | 0.37 | -0.05 | -0.13 | -0.37 | -0.08 | -0.02 | -0.05 | 0.32 | -0.39 |
| EPS in Rs | -0.03 | 0.61 | -0.08 | -0.21 | -0.61 | -0.13 | -0.03 | -0.08 | 0.53 | -0.59 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 |
| Reserves | 6.74 | 6.72 | 7.09 | 6.99 | 6.86 | 6.49 | 9.1 | 9.08 | 9.03 | 9.35 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.25 | 0.16 | 3.82 | 8.54 | 8.63 | 0.02 | 0.23 | 0.1 | 0.47 | 0.2 |
| Total Liabilities | 13.05 | 12.94 | 16.97 | 21.59 | 21.55 | 12.57 | 15.39 | 15.24 | 15.56 | 15.61 |
| Fixed Assets | 0.16 | 0.11 | 0.09 | 0.07 | 0.06 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 10 | 11.25 | 10 | 1.94 | 1.94 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2.89 | 1.58 | 6.88 | 19.58 | 19.55 | 12.52 | 15.36 | 15.21 | 15.53 | 15.58 |
| Total Assets | 13.05 | 12.94 | 16.97 | 21.59 | 21.55 | 12.57 | 15.39 | 15.24 | 15.56 | 15.61 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.82 | -0.06 | -1.23 | -4.36 | -0.05 | -2.38 | 2.95 | -0.01 | -0.02 | 0 |
| Cash from Investing Activity | 0.3 | -1.25 | 1.25 | 4.36 | 0.02 | 2.35 | -2.91 | 0 | 0 | 0 |
| Cash from Financing Activity | 1.33 | -0.05 | 0.06 | 0 | 0 | 0 | 0 | -0.01 | 0 | 0 |
| Net Cash Flow | 0.81 | -1.36 | 0.08 | -0.01 | -0.03 | -0.03 | 0.04 | -0.01 | -0.02 | 0 |
| Free Cash Flow | -0.99 | -0.06 | -1.23 | -4.36 | -0.05 | -2.38 | 2.95 | -0.01 | -0.02 | 0 |
| CFO/OP | 293 | -50 | -355 | 8660 | 31 | 486 | -3220 | 8 | 25 | 0 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ROE % | -3.19 | -0.16 | 4.24 | -0.38 | -1 | -2.91 | -0.58 | -0.13 | -0.33 | 2.1 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25.49% | 29.98% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 64.02% | 65.76% | 67.23% | 67.3% | 65.77% | 65.36% | 66.07% | 65.26% | 65.26% | 65.63% | 66% | 65.94% |
| Others | 10.98% | 9.24% | 7.77% | 7.7% | 9.23% | 9.64% | 8.93% | 9.74% | 9.74% | 9.37% | 8.51% | 4.08% |
| No. of Shareholders | 3465 | 3650 | 3792 | 3866 | 4107 | 4178 | 4302 | 4306 | 4315 | 4306 | 4295 | 4177 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 7 / 0

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 29.38 | Buy |
| EMA (10) | 29.41 | Buy |
| SMA (20) | 29.22 | Buy |
| EMA (20) | 29.13 | Buy |
| SMA (50) | 28.46 | Buy |
| EMA (50) | 28.69 | Buy |
| SMA (100) | 28.91 | Buy |
| EMA (100) | 27.92 | Buy |
| SMA (200) | 25.15 | Buy |
| EMA (200) | 25.61 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 55.82 | Neutral |
| MACD (12,26,9) | 0.36 | Buy |
| Stochastic (14,3,3) | 65.1 | Neutral |
| ADX (14) | 17.25 | Neutral |
| Williams %R (14) | -29.34 | Neutral |
| ATR (14) | 1.81 | High Volatility |
| ROC (12) | 5.16 | Buy |
| Stoch RSI (14) | 44.88 | Neutral |
| UO (7,14,28) | 56.49 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-26 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f554d74b-408c-401d-92bc-a9fda2ba40ec.pdf) |
| 2026-08-24 | [Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5a6549c-30ec-4d62-9b23-ec5e0c2eb1c4.pdf) |
| 2026-08-24 | [Notice Of 24Th Annual General Meeting.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03c22445-d365-4acd-9c90-a8a6e9dc7e15.pdf) |
| 2026-08-24 | [Annual Report For The Financial Year 2025-2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=122adf13-9d5b-48dd-97d9-edd88c9a0d92.pdf) |
| 2026-08-24 | [Annual Report For The Financial Year 2025-2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b43f4764-2228-405d-8301-765aed243264.pdf) |
| 2026-08-24 | [Intimation Of Book Closure.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46175d0a-15a5-4ab5-aef7-6733bcabc001.pdf) |
| 2026-08-24 | [Intimation Of Record Date.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e111d7a-6ba6-4aa6-87c0-009dd251d7c3.pdf) |
| 2026-08-19 | [Board Meeting Intimation for Regulation 29(1) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4322d54-61aa-4772-827c-bdca4786ea80.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5896b16a-5334-4dc9-b25a-8e6e7ee02a6b.pdf) |
| 2026-08-05 | [Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1bb5670-4325-4ec2-8f16-20191425e3e5.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 Feb - Board meeting on 13 Feb 2026 to consider unaudited quarter ended 31 Dec 2025 results. | [Board Meeting Intimation for Consideration, Approval And Taking On Record The Unaudited Standalone Financial Results Of The Company Along With The Limited Review Report For The Quarter Ended 31St December, 2025. 7 Feb - Board meeting on 13 Feb 2026 to consider unaudited quarter ended 31 Dec 2025 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a8f8a077-a74d-4565-844b-d1d8ab19be3f.pdf) |
| 7 Apr - Regulation 57(5) filing: no non-convertible securities or payment obligations due for Q1 2026. | [Compliance-57 (5) : intimation after the end of quarter 7 Apr - Regulation 57(5) filing: no non-convertible securities or payment obligations due for Q1 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a86b381d-dfa6-49ca-8901-128eaa7be796.pdf) |
| 7 Apr - Promoters reported no share encumbrance during FY ended 31 March 2026. | [Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 For The Financial Year Ended 31St March, 2026. 7 Apr - Promoters reported no share encumbrance during FY ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f741d75-9a0d-4ac5-b35b-487a7635ab80.pdf) |
| 6 Apr - No non-convertible securities; no interest, dividend or principal dues for Jan-March 2026. | [Compliance-57 (5) : intimation after the end of quarter 6 Apr - No non-convertible securities; no interest, dividend or principal dues for Jan-March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2d114e1e-42fd-4c4f-9f4d-89451eb619df.pdf) |
| 5 May - Board approved allotment of 75 lakh shares and 50 lakh warrants on preferential basis on May 5, 2026. | [Board Meeting Outcome for Outcome Of Board Meeting For Allotment Of Securities 5 May - Board approved allotment of 75 lakh shares and 50 lakh warrants on preferential basis on May 5, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fc473859-3a2a-4f4f-bd59-3f7803604e32.pdf) |
| 5 May - Board approved allotment of 75 lakh shares and 50 lakh convertible warrants on May 5, 2026. | [Announcement under Regulation 30 (LODR)-Allotment 5 May - Board approved allotment of 75 lakh shares and 50 lakh convertible warrants on May 5, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8d2b7578-07a5-4f4a-8452-65dd4dae4b69.pdf) |
| 5 Feb - Board meeting on Feb 10, 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window closed. | [Board Meeting Intimation for Unaudited Financial Results For Dec 31, 2025 5 Feb - Board meeting on Feb 10, 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a9bbf2e9-29c2-4cf5-ae80-1e5e666d45f3.pdf) |
| 30 Mar - Trading window closed from April 1, 2026 until 48 hours after Q4/FY2026 results. | [Closure of Trading Window 30 Mar - Trading window closed from April 1, 2026 until 48 hours after Q4/FY2026 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e02c21c1-010f-40c5-b89a-69dd8bcb9e7b.pdf) |
| 30 Mar - Company states no interest/dividend/principal payable on non-convertible securities for April–June 2026 quarter. | [Intimation Under Regulation 57(4) Of SEBI (LODR) Regulations, 2015. 30 Mar - Company states no interest/dividend/principal payable on non-convertible securities for April–June 2026 quarter.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/43ebdf88-dffa-43ff-b388-e18885992a26.pdf) |
| 30 Mar - Clarification (27-Feb-2026): no undisclosed material information; price movement market-driven; promoters/KMPs haven't traded. | [Clarification With Respect To Significant Movement In The Price Of Our Security At The Stock Exchange. 30 Mar - Clarification (27-Feb-2026): no undisclosed material information; price movement market-driven; promoters/KMPs haven't traded.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/24bacd17-9f89-4be5-92de-244e5cada626.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a291acc8-3ab0-4258-8283-f8b6f61d2fcf.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2025-02-14 | [Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29a910f4-5e76-427e-b282-6301e399e6ff.pdf) |
| 2023-11-09 | [Revision In Outcome Of Board Meeting Held On 08Th November, 2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f3638f9-e884-4a7d-bac7-22e8103bebc8.pdf) |
| 2023-11-08 | [Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f53bb78-0815-47d3-bc91-e6963fd76885.pdf) |
| 2023-08-14 | [Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b275b1e2-4acf-4ccb-9546-93fa091b84f9.pdf) |
| 2023-05-30 | [Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac3304c8-82e6-456b-a8c3-d7a5f89162dd.pdf) |
| 2023-02-13 | [Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2544a4a0-6090-4a49-a14a-74e77eb8e319.pdf) |
| 2022-11-17 | [Clarification/Resubmission - Outcome Of Board Meeting Held On 14Th November, 2022.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7996c5ed-46a1-4acb-97eb-9a67c72b76d6.pdf) |
| 2022-11-14 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76fd5e45-88e0-4223-b583-093757d4bbce.pdf) |
| 2022-08-16 | [Clarification/Resubmission - Outcome Of Board Meeting Held On 13Th August, 2022.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f49edbf-d079-4192-bfa5-1c1d087475d7.pdf) |
| 2022-08-13 | [Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c66642fa-2c5f-4b94-8880-1dab85263226.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4bb378f8-efc5-448d-a01a-b5c4b88eca5c.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce46afd1-21c1-4467-afe1-403b90b697d0.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/06bbe06d-8504-48b1-8f2f-5dae3a330ba2.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/87884853-7bd1-4e9b-ad96-3b17a4c8a708.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bcfb19dc-4373-4c5f-9bd4-318034fac607.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539177/75297539177.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/512217/77007512217.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539177/70739539177.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/512217/69935512217.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/539177/66125539177.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:00.773Z.